To evaluate if treatment with a new drug reduces the risk cardiovascular disease in patients with established cardiovascular disease, chronic kidney disease and inflammation.
To be considered for the study you must meet the following criteria:
- Aged 18 years or older
- Evidence of cardiovascular disease
- History of chronic kidney disease and inflammation
Your participation in this study would be for approximately 3 years.
You will need to attend the clinic for an initial assessment where a small blood sample will be taken. Eligible participants are required to attend a series of in clinic appointments over the life of the study for drug dispensation and a blood test. During these visits you will also be asked about your health and medications.
You will be reimbursed for travel and study related expenses.
Joondalup – Shenton House (Cardiology)